Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for ...

The regulatory agency will review MSD’s new drug application (NDA) for Welireg under a Priority Review, with a Prescription ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Tevogen Bio has expanded its partnership with Microsoft, aiming to further their collaboration centred on AI and advance ...

The UK biotech sector raised £3.5bn in 2024, the highest annual total since 2021 when £4.5bn was raised. The UK biotech ...

The FDA has approved the sBLA of Eisai and Biogen's LEQEMBI for maintenance dosing indicated for the early stages of ...

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

Amgen has inaugurated its new drug substance facility in the US after announcing a $1bn further expansion at the North ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...

The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.

Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...